Read + Share
Rai S, Kim WS, Ando K, Choi I, et al. Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory
peripheral T-cell lymphoma: phase IIb results. Haematologica 2022 Oct 6. doi: 10.3324/haematol.2022.280996.
PMID: 36200417
|
 |
|
Rai S, Kim WS, Ando K, Choi I, et al. Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory
peripheral T-cell lymphoma: phase IIb results. Haematologica 2022 Oct 6. doi: 10.3324/haematol.2022.280996.
PMID: 36200417
|
|
|
|